142 related articles for article (PubMed ID: 21565957)
21. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
[TBL] [Abstract][Full Text] [Related]
22. F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.
Takahashi Y; Takashima S; Watanabe S; Tomita Y; Hakucho T; Miyake C; Morimoto D; Hosoki T; Nakanishi K; Higashiyama M
Acta Radiol; 2013 Mar; 54(2):164-8. PubMed ID: 23138022
[TBL] [Abstract][Full Text] [Related]
23. Utility of respiratory-gated small-animal PET/CT in the chronologic evaluation of an orthotopic lung cancer transplantation mouse model.
Otani T; Otsuka H; Kondo K; Takizawa H; Nagata M; Kishida M; Miyoshi H
Radiol Phys Technol; 2015 Jul; 8(2):266-77. PubMed ID: 25921487
[TBL] [Abstract][Full Text] [Related]
24. [Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis].
Wang Y; Zhang H; Cui X; Fang N; Zeng L; Zhang C
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Mar; 32(3):186-9. PubMed ID: 24641846
[TBL] [Abstract][Full Text] [Related]
25. Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.
Salavati A; Borofsky S; Boon-Keng TK; Houshmand S; Khiewvan B; Saboury B; Codreanu I; Torigian DA; Zaidi H; Alavi A
Mol Imaging Biol; 2015 Feb; 17(1):140-8. PubMed ID: 25080325
[TBL] [Abstract][Full Text] [Related]
26. Dual-time-point
Huang YE; Huang YJ; Ko M; Hsu CC; Chen CF
Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555
[TBL] [Abstract][Full Text] [Related]
27. Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume.
Callahan J; Kron T; Schneider-Kolsky M; Dunn L; Thompson M; Siva S; Aarons Y; Binns D; Hicks RJ
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):749-54. PubMed ID: 23601897
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
29. Impact of free-breathing CT on quantitative measurements of static and quiescent period-gated PET Images.
Meier JG; Einstein SA; Diab RH; Erasmus LJ; Xu G; Mawlawi OR
Phys Med Biol; 2019 May; 64(10):105013. PubMed ID: 31026840
[TBL] [Abstract][Full Text] [Related]
30. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
31. Respiratory-gated time-of-flight PET/CT during whole-body scan for lung lesions: feasibility in a routine clinical setting and quantitative analysis.
Suzawa N; Ichikawa Y; Ishida M; Tomita Y; Nakayama R; Sakuma H
Ann Nucl Med; 2016 Dec; 30(10):722-730. PubMed ID: 27566685
[TBL] [Abstract][Full Text] [Related]
32. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
[TBL] [Abstract][Full Text] [Related]
34. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
[TBL] [Abstract][Full Text] [Related]
35. Serial changes of FDG uptake and diagnosis of suspected lung malignancy: a lesion-based analysis.
Cheng G; Alavi A; Werner TJ; Del Bello CV; Akers SR
Clin Nucl Med; 2014 Feb; 39(2):147-55. PubMed ID: 24368534
[TBL] [Abstract][Full Text] [Related]
36. Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours.
van Elmpt W; Hamill J; Jones J; De Ruysscher D; Lambin P; Ollers M
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):843-55. PubMed ID: 21222120
[TBL] [Abstract][Full Text] [Related]
37. Deep-inspiration breath-hold PET/CT of lung cancer: maximum standardized uptake value analysis of 108 patients.
Kawano T; Ohtake E; Inoue T
J Nucl Med; 2008 Aug; 49(8):1223-31. PubMed ID: 18632812
[TBL] [Abstract][Full Text] [Related]
38. Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.
Basu S; Kung J; Houseni M; Zhuang H; Tidmarsh GF; Alavi A
Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):9-19. PubMed ID: 18337683
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC
Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Chirindel A; Chaudhry M; Blakeley JO; Wahl R
J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
